Skip to main content
. 2010 Nov 10;2010(11):CD005197. doi: 10.1002/14651858.CD005197.pub3

Bow 2006.

Methods RCT
 Open
Participants Number: 528 patients
 Age not given
Interventions piperacillin‐tazobactam 4.5grx4
 versus
 cefepime 2grx3
Outcomes Overall and infection‐related mortality ‐ at 7 days following end of treatment
 Clinical and microbiological failure
 Drug modifications
Notes MC USA,Canada,Australia
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation? Low risk Computer generated sequence
Allocation concealment? Low risk Central
Blinding? 
 All outcomes High risk No blinding used
Incomplete outcome data addressed? 
 All‐cause mortality Low risk  
Incomplete outcome data addressed? 
 Treatment failure Low risk  
Free of other bias? Low risk Unit of randomization = patients